ReviewRisk management and healthcare policy2020
COVID-19 in Children: An Ample Review.
Review in Risk management and healthcare policy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 57 citations in OpenAlex.
- Can Lung Ultrasound Act as a Diagnosis and Monitoring Tool in Children with Community Acquired Pneumonia? Correlation with Risk Factors, Clinical Indicators and Biologic Results.Journal of clinical medicine · 2025Article
- COVID-19 vaccine confidence, concerns, and uptake in children aged 5 and older in Calgary, Alberta: a longitudinal cohort study.Paediatrics & child health · 2024Article
- Exploring the prevalence and chest CT predictors of Long COVID in children: a comprehensive study from Shanghai and Linyi.Frontiers in pediatrics · 2024Article
- Factors Influencing the Use and Demand of New Coronavirus Therapy Drugs Among the Adults During COVID-19 in China.Risk management and healthcare policy · 2024Article
- Chest Physiotherapy Interventions for Children During SARS-COV-2 Pandemic.Clinical pediatrics · 2024Review
- Monitoring COVID-19 spread in selected Prague's schools based on the presence of SARS-CoV-2 RNA in wastewater.The Science of the total environment · 2023Article
- How has the COVID-19 pandemic impacted clinical care and research in Neuro-Oncology?Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2022Review
- Severe pulmonary hemorrhage in a 3-week-old neonate with COVID-19 infection: A case report.Clinical case reports · 2022Article
- Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study.The Lancet. Child & adolescent health · 2022Observational
- COVID-19: potential therapeutics for pediatric patients.Pharmacological reports : PR · 2021Review
- Prevalence of SARS-CoV-2 Infection in Children by Antibody Detection in Saliva: Protocol for a Prospective Longitudinal Study (Coro-Buddy).JMIR research protocols · 2021Article
- Clinical features and outcome of COVID-19 positive children from a tertiary healthcare hospital in Karachi.Journal of medical virology · 2021Article
- Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland.Journal of clinical virology plus · 2021Article
- Immune Response to SARS-CoV-2 in an Asymptomatic Pediatric Allergic Cohort.Antibodies (Basel, Switzerland) · 2021Article
- Managing children with brain tumors during the COVID-19 era: Don't stop the care!Computational and structural biotechnology journal · 2021Review
- Multisystem Inflammatory Syndrome in Children and Adolescents (MIS-C) under the Setting of COVID-19: A Review of Clinical Presentation, Workup and Management.Infectious diseases · 2021Review
- Racial and Ethnic Disparities in COVID-19 Outcomes: Social Determination of Health.International journal of environmental research and public health · 2020Article
- Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children.Journal of pediatric nursingReview
- Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations.Jornal de pediatriaReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this review was to describe the current knowledge about coronavirus disease 2019 (COVID-19, which is caused by severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) in children, from epidemiological, clinical, and laboratory perspectives, including knowledge on the disease course, treatment, and prognosis. An extensive literature search was performed to identify papers on COVID-19 (SARS-CoV-2 infection) in children, published between January 1, 2020 and April 1, 2020. There were 44 relevant papers on COVID-19 in children. The results showed that COVID-19 occurs in 0.39-12.3% of children. Clinical signs and symptoms are comparable to those in adults, but milder forms and a large percentage of asymptomatic carriers are found among children. Elevated inflammatory markers are associated with complications and linked to various co-infections. Chest computed tomography (CT) scans in children revealed structural changes similar to those found in adults, with consolidations surrounded by halos being somewhat specific for children with COVID-19. The recommended treatment includes providing symptomatic therapy, with no specific drug recommendations for children. The prognosis is much better for children compared to adults. This review highlights that COVID-19 in children is similar to the disease in the adult population, but with particularities regarding clinical manifestations, laboratory test results, chest imaging, and treatment. The prognosis is much better for children compared to adults, but with the progression of the pandemic; the cases in children might change in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.